| Titolo |
Pubblicato in |
Anno |
| Procognitive Potential of Neuroprotective Triazine 5-HT6 Receptor Antagonists Tested on Chronic Activity In Vivo in Rats: Computer-Aided Insight into the Role of Chalcogen-Differences on the Pharmacological Profile |
ACS CHEMICAL NEUROSCIENCE |
2025 |
| First-in-Class Selenium-Containing Potent Serotonin Receptor 5-HT6 Agents with a Beneficial Neuroprotective Profile against Alzheimer's Disease |
JOURNAL OF MEDICINAL CHEMISTRY |
2024 |
| Selenium-containing compounds: a new hope for innovative treatments in Alzheimer’s disease and Parkinson’s disease |
DRUG DISCOVERY TODAY |
2024 |
| m6A modification inhibits miRNAs’ intracellular function, favoring their extracellular export for intercellular communication |
CELL REPORTS |
2024 |
| Unlocking the potential of higher-molecular-weight 5-HT7R ligands: Synthesis, affinity, and ADMET examination |
BIOORGANIC CHEMISTRY |
2024 |
| Novel 1,4-Dihydropyridines as Specific Binders and Activators of SIRT3 Impair Cell Viability and Clonogenicity and Downregulate Hypoxia-Induced Targets in Cancer Cells |
JOURNAL OF MEDICINAL CHEMISTRY |
2023 |
| SYNCRIP Modulates the Epithelial-Mesenchymal Transition in Hepatocytes and HCC Cells |
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
2022 |
| Next RNA therapeutics: the mine of non-coding |
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
2022 |
| Seleno-vs. thioether triazine derivatives in search for new anticancer agents overcoming multidrug resistance in lymphoma |
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY |
2022 |
| Restoration of WT1/miR-769-5p axis by HDAC1 inhibition promotes MMT reversal in mesenchymal-like mesothelial cells |
CELL DEATH & DISEASE |
2022 |
| MyoD-Induced Trans-Differentiation: A Paradigm for Dissecting the Molecular Mechanisms of Cell Commitment, Differentiation and Reprogramming |
CELLS |
2022 |
| Selenium-Containing Agents Acting on Cancer—A New Hope? |
PHARMACEUTICS |
2022 |
| lncRNA HOTAIR functions and therapeutic perspectives |
ONCOSCIENCE |
2022 |
| m6A RNA methylation and beyond - the epigenetic machinery and potential treatment options |
DRUG DISCOVERY TODAY |
2021 |
| A novel RNA-based approach to counteract EMT |
ONCOSCIENCE |
2021 |
| Design and functional validation of a mutant variant of the lncRNA HOTAIR to counteract Snail function in Epithelial-to-Mesenchymal Transition |
CANCER RESEARCH |
2020 |
| The lncRNA H19 positively affects the tumorigenic properties of glioblastoma cells and contributes to NKD1 repression through the recruitment of EZH2 on its promoter |
ONCOTARGET |
2018 |
